The Claim

Variants in the SLC2A9 gene are associated with reduced fractional excretion of uric acid, indicating that these genetic differences influence renal uric acid clearance.

Source: SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
44score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

People with certain versions of the SLC2A9 gene excrete less uric acid in their urine, meaning their kidneys remove less uric acid from the blood.

See the scientific wording

Variants in the SLC2A9 gene are associated with reduced fractional excretion of uric acid, indicating that these genetic differences influence how the kidneys remove uric acid from the blood.

Why this might work

Proteins in the kidney that pull uric acid from the blood into the urine tubes work less effectively when certain gene versions are present, so less uric acid gets removed from the blood and more stays in circulation.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

    People with certain versions of the SLC2A9 gene have kidneys that don’t flush out uric acid as well, so it builds up in their blood — and this study found that exact link in thousands of people.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.